Amir Mohammad Saeedifar

Amir Mohammad Saeedifar

Auto-generated profile, based on publicly available information

Amir Mohammad Saeedifar

Department of Immunology, School of Medicine, Arak university of Medical Sciences, Arak, Iran

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2022 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MSMaryam Shamsi
Maryam Shamsi
AGAli Ghazavi
Ali Ghazavi
ASAmir Mohammad Saeedifar
Amir Mohammad Saeedifar
GMGhasem Mosayebi
Ghasem Mosayebi
SPSana Khajeh pour
Sana Khajeh pour
AGAli Ganji
Ali Ganji

2 February 2023 in Gene Reports
Verified
Journal Article
Closed access
ASAmir Mohammad Saeedifar
Amir Mohammad Saeedifar
KGKhodayar Ghorban
Khodayar Ghorban
AGAli Ganji
Ali Ganji
GMGhasem Mosayebi
Ghasem Mosayebi
MGMohammad Gholami
Mohammad Gholami
NRNegin Hosseini Rouzbahani
Negin Hosseini Rouzbahani

29 June 2024 in International Journal of Basic Science in Medicine
Verified
Journal Article
Closed access
IFIman Farahani
Iman Farahani
ASAmir Mohammad Saeedifar
Amir Mohammad Saeedifar
AGAli Ghazavi
Ali Ghazavi
GMGhasem Mosayebi
Ghasem Mosayebi
AGAli Ganji
Ali Ganji
Introduction: Detoxification drugs used for opium (OPM) withdrawal, such as buprenorphine (BUP), naltrexone (NTX), and methadone (MTD), can have inhibitory effects. In a recent study, the impact of OPM and these detoxification drugs on cytokines secreted by RAW 264.7 macrophages was examined. Methods: The M1 model (positive control) included lipopolysaccharide (LPS)-stimulated macrophages, while the M0 model (negative control) included DMSO-treated macrophages. The study measured the ratios of inflammatory (IFN-γ, TNF-α, IL-6) to anti-inflammatory cytokines (IL-10, TGF-β) secreted by RAW 264.7 macrophages exposed to OPM and the detoxification drugs using real-time polymerase chain reaction (PCR). Results: The results showed that in the M1 model, the ratio of IFN-γ/IL-10 significantly increased with OPM+MTD (P<0.001) and OPM+BUP (P<0.05). Similarly, the INF-γ/TGF-β ratio increased significantly with OPM+MTD (P<0.001), OPM+BUP (P<0.01), and OPM+NTX (P<0.05) compared to the negative control. Compared to the M0 model, the TNF-α/IL-10 and TNF-α/TGF-β ratios showed the highest increase with OPM+BUP (P<0.001) and OPM+MTD (P<0.01). Additionally, OPM+BUP (P<0.001) and OPM+MTD (P<0.05) exhibited the greatest increase in the IL-6/IL-10 ratio, and OPM+BUP (P<0.001) also showed a significant upward trend in the IL-6/TGF-β ratio. Conclusion: These findings suggest that BUP and MTD may have the potential to be used as therapies for reducing inflammation in OPM-treated macrophages by increasing M1 cytokines and enhancing immune responses.